Switching from TNFα inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFα inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trial

Youn‐Sang Jung(Chung-Ang University), Wan‐Uk Kim(Catholic University of Korea), Ki-Jo Kim(The Catholic University of Korea St. Vincent's Hospital), Jung Hee Koh(The Catholic University of Korea Bucheon St. Mary's Hospital), Sung Jae Choi(Korea University), Jisoo Lee(Ewha Womans University), Yong-Wook Park(Chonnam National University Hospital), Hyung-In Yang(Kyung Hee University), Chan‐Bum Choi(Hanyang University Seoul Hospital)
Arthritis Research & Therapy
July 8, 2021
Cited by 2


Related Papers